Sarah Cannon Research Institute at SABCS 2026

Dec 8–11, 2026 San Antonio, TX ~11k attendees Website

Sarah Cannon Research Institute brings 8 presentations to SABCS 2026 in San Antonio. The Nashville research organization presents trials of vepdegestrant, patritumab deruxtecan and a Rac-Cdc42 inhibitor, real-world endocrine therapy uptake, and takes a panel seat and a moderator seat.

OrganizationSABCS 2026 Attendance
Services
Clinical research organization that conducts oncology clinical trials with participating research sites.
Session
Wed Dec 9
noon–1pm
Clinical Case Discussion
Stars at Night 1-2
Poster
Thu Dec 10
12:30–2pm
Real-world adjuvant endocrine therapy treatment uptake among patients with hr+,her2− early breast cancer in 2015-2025
Exhibit Hall
Breast Cancer: Early Stage - Hormone Receptor Positive
Session
Thu Dec 10
2:30–4:15pm

Explore the full SABCS 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full SABCS 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Sarah Cannon Research Institute

Tell us what you sell and we’ll find the people at Sarah Cannon Research Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction